Advertisement

Loading...

MetaVia Inc.

MTVA•NASDAQ
Healthcare
Biotechnology
$1.28
$0.11(9.40%)
U.S. Market is Open • 13:42

MetaVia Inc. (MTVA) Stock Overview

Explore MetaVia Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.6M
P/E Ratio-0.22
EPS (TTM)$-7.35
ROE-2.02%
Fundamental Analysis

AI Price Forecasts

1 Month$1.11
3 Months$2.33
1 Year Target$8.00

MTVA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MetaVia Inc. (MTVA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 24.82, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $8.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.22 and a market capitalization of 2.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.56%
5-Day Change
-7.69%
1-Month Change
-20.53%
3-Month Change
-85.75%
6-Month Change
-88.39%
Year-to-Date (YTD) Change
-87.45%
1-Year Change
-92.92%
3-Year Change
-95.69%
5-Year Change
-95.69%
All-Time (Max) Change
-95.69%

Contact Information

https://www.metaviatx.com
857 702 9600
545 Concord Avenue, Cambridge, MA, 02138

Company Facts

90 Employees
IPO DateAug 5, 2016
CountryUS
Actively Trading

Frequently Asked Questions